Sphera Biotech Master Fund

Sphera Biotech Master Fund is an investment vehicle specializing in innovative small and mid-cap companies in the global biotechnology sector. It employs a research-driven approach, leveraging a dedicated team of scientists, doctors, and experts in Tel Aviv. This team organizes analysis by therapeutic category, gaining deep insights into treatment modalities and detecting disruptive technologies.

Sphera Biotech launched in 2018 as a specialized fund under Sphera Funds Management. Doron Breen, Ron Senator, and Israel Mor co-founded Sphera Funds Management in 2004. Their insight adapted disciplined, research-intensive methodology for the complex biotechnology landscape, applying expertise to identify promising early-stage life science innovations.

The fund serves sophisticated investors, including prominent pension funds and family offices, aiming for strong, risk-adjusted returns through its specialized biotech investments. Sphera Biotech's vision is to consistently identify and support companies at the forefront of medical innovation, driving financial growth and advancing impactful new therapies.